Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma

Clinical trial NCT02867618 · TERMINATED

Trial details

NCT number: NCT02867618
Sponsor: Columbia University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin Disease Lymphoma, Non-hodgkin

Start date: 2016-10-16
Primary completion: 2020-06-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.